Kendall Law Group, led by former federal judge Joe Kendall, is investigating Synovis Life Technologies Inc. (NASDAQ: SYNO) for shareholders in connection with the proposed acquisition by Baxter International Inc. The national securities firm’s investigation seeks to determine whether Synovis and its Board breached their fiduciary duties by entering into the agreement without properly shopping for a deal that would provide better value for shareholders. If you are a Synovis shareholder and would like additional information about your rights, contact the Kendall Law Group at 877-744-3728 or by email at investor@kendalllawgroup.com.

On December 13, 2011, the companies announced the definitive merger agreement under which Synovis would be acquired by Baxter, in a transaction valued at approximately $325 million. Under the terms of the agreement, Synovis stockholders will receive $28.00 in cash for each share of SYNO common stock held. The firm’s investigation seeks to determine whether Synovis and its Board undertook a fair process in negotiating the deal.

Kendall Law Group was founded by a former federal judge, includes a former United States Attorney, prosecutors and securities lawyers who are experienced in complex securities litigation. The firm has been counsel in numerous merger and acquisition cases nationwide, including some of the largest transactions in the United States.

Grafico Azioni Synovis Life Technologies, Inc. (MM) (NASDAQ:SYNO)
Storico
Da Mag 2024 a Giu 2024 Clicca qui per i Grafici di Synovis Life Technologies, Inc. (MM)
Grafico Azioni Synovis Life Technologies, Inc. (MM) (NASDAQ:SYNO)
Storico
Da Giu 2023 a Giu 2024 Clicca qui per i Grafici di Synovis Life Technologies, Inc. (MM)